Navigation Links
BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
Date:5/20/2008

NOVATO, Calif., May 20 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) today announced that the first patient has initiated treatment in the Phase 1 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU). The study is expected to conclude enrollment in the fourth quarter of 2008.

"We are dedicated to serving the PKU community and hope to address the entire spectrum of PKU patients between PEG-PAL and Kuvan. We believe PEG-PAL holds tremendous potential to bring blood Phe down to normal levels and may help patients who either do not respond to Kuvan or who wish to reduce blood Phe levels beyond what is possible with Kuvan," said Jean-Jacques Bienaime, Chief Executive Officer of BioMarin. "Positive preclinical data shows sustained decreases in blood Phe levels in PKU mice without any notable safety concerns and we hope to see the same results in humans."

The Phase 1 clinical trial is an open-label, multi-center study to be conducted in approximately 35 PKU patients in a series of seven dose- escalating cohorts ranging from 0.001 to 1.0 mg/kg, with each cohort receiving a single dose, and a 6-week follow-up period.

The primary objective of the study is to assess the safety and tolerability of single, subcutaneous injections of PEG-PAL in subjects with PKU. The secondary objectives of the study are to evaluate the pharmacokinetics of single, subcutaneous injections of PEG-PAL administered at escalating doses and to evaluate the effect of PEG-PAL on blood Phe concentrations in subjects with PKU.

About PEG-PAL

PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) is an investigational enzyme substitution therapy for the treatment of PKU. Pharmacology studies conducted in the PKU mouse model demonstrated that weekly subcutaneous administrations of PEG-PAL resulted in a significant and stable decrease of plasma phenylalanine. BioMar
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioMarin Announces FDA Approval for Kuvan
2. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
3. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
4. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
5. Go Healthy Initiates Additional Clinical Tests on Cholesterade
6. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
7. Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in Patients With Relapsed Solid Tumors
8. Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845
9. Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
10. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
11. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Silicon Valley Bank, ... a study today that examines the merger, acquisition ... device companies.  According to the annual report based on ... potential returns since SVB started tracking the data in ... IPO.  Built on solid healthcare M&A activity over the ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 ... products for oncology supportive care, announced that its novel ... featured in an article on OncLive.com titled, "Study Finds ... Neck Cancers."  Dr. Steve Sonis , a leading ... demand seen in the oncology community for evidence-based strategies ...
(Date:7/30/2014)...   Medical Equipment Solutions, Corp. are pleased ... of Defense (US Army) contract valued at over $2 ... diagnostic machine and technical support staffing. As an 8-A ... Business Administration (SBA), Medical Equipment is proud to support ... medical diagnostic equipment. The SBA 8-A certification is a ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... , Feb. 10 CORD:USE Cord Blood Bank ... System, the fifth-largest public healthcare system in the nation, to ... global registry for patients in need of a potentially life-saving ... will allow CORD:USE to continue building the National Cord Blood ...
... , , ... Cell-Teva Joint Venture,(JV) announced today that the Data Monitoring Committee (DMC) ... of StemEx (called ExCell) and has recommended that the JV,continue to ... take place during Q2 2010. StemEx is being evaluated as a,therapeutic ...
Cached Medicine Technology:CORD:USE Cord Blood Bank Announces Partnership with Memorial Healthcare System 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3
(Date:7/30/2014)... the children at Father’s Home come from different backgrounds ... to mar their respective psychosocial development. There appears to ... has underpinnings in a healthy adolescence and in this ... foreseeable future, would assist in developing the youth. , ... of Foundation members in that remote location – as ...
(Date:7/30/2014)... Kathleen Doheny HealthDay ... Dieting at a young age might set the stage for ... Surveys of college-age women conducted from 1982 to 2012 ... and alcohol abuse. "The younger a woman was when ... [later] to use extreme weight control behaviors -- like vomiting ...
(Date:7/30/2014)... Dennis Thompson HealthDay Reporter ... fruits and vegetables are vital to good health and a ... hit five servings of fruits and vegetables each day, additional ... review suggests. The human body may only be able ... every day, limiting its ability to absorb important nutrients from ...
(Date:7/30/2014)... (USP) have identified an RNA known as INXS that, ... protein, modulates the action of an important gene in ... , According to Sergio Verjovski-Almeida, professor at the USP ... So Paulo Research Foundation (FAPESP), INXS expression is generally ... of stimulating the production of this non-coding RNA can ...
(Date:7/30/2014)... Florida A&M University ( FAMU ) ... professor Ngozi Ugochukwu, Ph.D., will head to Nigeria ... The prestigious Fulbright Scholars Program is a highly ... to students, faculty or professionals who wish to ... and Ugochukwu will conduct respective research on the ...
Breaking Medicine News(10 mins):Health News:The Edusei Foundation Donates Food and Assorted Items to the Fathers’ Home Care Ministries in Takoradi, Ghana 2Health News:Dieting at Young Age Often Backfires, Study Says 2Health News:Dieting at Young Age Often Backfires, Study Says 3Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3Health News:Brazilian researchers identify RNA that regulates cell death 2Health News:Brazilian researchers identify RNA that regulates cell death 3Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3
... useless, the appendix now appears to have a reason to ... living in the human gut. , Drawing upon a series ... that the beneficial bacteria in the appendix that aid digestion ... the intestines and emerge afterwards to repopulate the gut. Their ...
... insights into chronic, illnesses, including heart failure and COPD, from ... ... Calif., Oct. 8 VivoMetrics announced today,that noted researcher Bruce D. Johnson, ... LifeShirt(R) System to,the South Pole to collect valuable data for his ongoing ...
... Prescription Pads with ... Enhanced Patient Features, HASBROUCK ... prescription pads, today announced that,it has appointed Richard Zwickel to ... model. Being launched this,month at the PDMA Sharing Conference in ...
... mothers who survived ... breast cancer, ALPHARETTA, Ga., ... brand, celebrates the "Power of Pink" by,announcing the winners of its "Pink ... women will be recognized,during the Susan G. Komen for the Cure Pink ...
... scrapes and bruises, study found , MONDAY, Oct. 8 (HealthDay ... as a non-lethal way to incapacitate suspects, are generally safe ... say U.S. researchers who reviewed almost 1,000 incidents involving the ... to a Taser had mild injuries (such as scrapes and ...
... to More Than Half the Population of Singapore to Use ... ... Facilities -, BOCA RATON, Fla., ... today announced,that SingHealth, the largest healthcare provider in Singapore, has selected,Eclipsys ...
Cached Medicine News:Health News:Appendix isn't useless at all: It's a safe house for bacteria 2Health News:Appendix isn't useless at all: It's a safe house for bacteria 3Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 2Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 3Health News:Medi-Promotions Hires Industry Executive to Expand its Medi-Scripts Prescription Pad Model 2Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 2Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 3Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 4Health News:Serious Injury Rare With Police Tasers 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 3
This versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
... is ALOKAs answer to the ... Super High Density, versatile convex ... offering 5 levels of fundamental ... settings of Harmonic frequencies. This ...
The versatility of multiple imaging frequencies and a smaller transducer face make this transducer is perfect for intercostal imaging....
Medicine Products: